Related Experiment Video
Updated: Jan 20, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
Understanding Dry Powder Inhalers: Key Technical and Patient Preference Attributes
Mark L Levy1, Will Carroll2, José L Izquierdo Alonso3
1Sessional General Practitioner, Kenton Bridge Medical Centre, London, UK. marklevy@animalswild.com.
Abstract:
Inhalable medications for patients with asthma and chronic obstructive pulmonary disease (COPD) can be confusing even for health care professionals because of the multitude of available devices each with different operating principles. Dry powder inhalers (DPI) are a valuable option for almost all of the patients with asthma or COPD. Based on recorded patient inspiratory profiles, the peak inspiratory flow requirement of 30 L min-1 of high-resistance devices does not usually pose any practical limitations for the patients. Suboptimal adherence and errors in device handling are common and require continuous checking and patient education in order to avoid these pitfalls of all inhalation therapy. The aim of this opinion paper is to describe the working principles of DPIs and to summarise their key properties in order to help prescribing the correct inhaler for each patient.Funding: Orion Pharma.
Related Concept Videos
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
04:59Disposable Dosators Intended for Dry Powder Delivery to Mice
07:55Intratracheal Administration of Dry Powder Formulation in Mice
Attribution Theory
Fundamental Attribution Error
Attribution

